This podcast from Dr. Peter Attia is a great resource. He is discussing rapamycin as with two of the leading authorities on the molecule. Dr. David Sabatini discovered how rapamycin works to slow aging and delay chronic illness by inhibiting the mechanistic target of rapamycin (mTOR). He is the leading authority on the basic science of mTOR and rapamycin. Dr. Matt Kaeberlein is the founder and director of the University of Washington Healthy Aging and Longevity Research Institute. He is a leader in the practical use of rapamycin to slow aging and delay chonic disease. This is a very engaging discussion aimed at laymen. It is long, but if you have any interest in a longer healthier life, it is well worth your time. I have been focused on this topic for a long time and I learned a lot of practical information. I hope you will listen to the podcast. In the next post, I will write about practical ways that you can benefit from this landmark science now. I am intested in what you think about the conversation!
4 Comments
2 more comments...No posts
Hello Dr Bestermann,
are there still medicines on the US market?
In Europe, there are only tests underway
Thanks
https://youtu.be/juBM2UJkMJY?si=WMWLUNw4ynVTfmOH this is the link to rapamycin compared/ contrasted to metformin. Seems like it is the next " thing".